MIDAS member Dr. Eva Harris awarded grant as part of new NIAID Centers for Research in Emerging Infectious Diseases

The National Institute of Allergy and Infectious Diseases (NIAID) announced it has established the Centers for Research in Emerging Infectious Diseases (CREID). The global network will involve multidisciplinary investigations into how and where viruses and other pathogens emerge from wildlife and spillover to cause disease in people.

“Each Center in the network will involve collaborations with peer institutions in the United States and 28 other countries. Research projects will include surveillance studies to identify previously unknown causes of febrile illnesses in humans; find the animal sources of viral or other disease-causing pathogens; and determine what genetic or other changes make these pathogens capable of infecting humans. CREID investigators also will develop reagents and diagnostic assays to improve detection of emerging pathogens and study human immune responses to new or emerging infectious agents. Overall, the breadth of research projects in the CREID network will allow for study of disease spillover in multiple phases of the process: where pathogens first emerge from an animal host; at the borders between wild and more populated areas, where human-to-human transmission occurs; and, finally, in urban areas, where epidemic spread can occur.”

MIDAS member Dr. Eva Harris is PI of one of the new Centers: American and Asian Centers for Arboviral Research and Enhanced Surveillance (A2CARES).  “The overarching goals of A2CARES are to develop an interconnected, harmonized network of clinical and laboratory sites to strengthen research programs, compare disease epidemiology and severity in different geographic regions, develop and implement cutting-edge diagnostic methods, and respond efficiently and effectively to outbreaks.”